Cargando…

Azithromycin combination therapy for community-acquired pneumonia: propensity score analysis

Whether macrolide combination therapy reduces the mortality of patients with severe community-acquired pneumonia (CAP) hospitalized in the non-intensive care unit (ICU) remains unclear. Therefore, we investigated the efficacy of adding azithromycin to β-lactam antibiotics for such patients. This pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ito, Akihiro, Ishida, Tadashi, Tachibana, Hiromasa, Tokumasu, Hironobu, Yamazaki, Akio, Washio, Yasuyoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895050/ https://www.ncbi.nlm.nih.gov/pubmed/31804572 http://dx.doi.org/10.1038/s41598-019-54922-4

Ejemplares similares

Prognostic factors in hospitalized community-acquired pneumonia: a retrospective study of a prospective observational cohort
por: Ito, Akihiro, et al.
Publicado: (2017)

Time Trend of the Sensitivity of the Pneumococcal Urinary Antigen Test for Diagnosing Pneumococcal Community-Acquired Pneumonia: An Analysis of 15-Year, Prospective Cohort Data
por: Ito, Akihiro, et al.
Publicado: (2021)

Legionella pneumonia due to non-Legionella pneumophila serogroup 1: usefulness of the six-point scoring system
por: Ito, Akihiro, et al.
Publicado: (2017)

A model for predicting bacteremia in patients with community-acquired pneumococcal pneumonia: a retrospective observational study
por: Washio, Yasuyoshi, et al.
Publicado: (2018)

The prognostic performance of qSOFA for community-acquired pneumonia
por: Tokioka, Fumiaki, et al.
Publicado: (2018)

Diagnostic markers for community-acquired pneumonia
por: Ito, Akihiro, et al.
Publicado: (2020)

Appropriate prescribing of azithromycin for community‐acquired pneumonia
por: Qian, Sue, et al.
Publicado: (2022)

Development and validation of a new scoring system for prognostic prediction of community-acquired pneumonia in older adults
por: Shirata, Masahiro, et al.
Publicado: (2021)

2590. Efficacy of Doxycycline Versus Azithromycin in Community Acquired Pneumonia
por: Mei, Julie, et al.
Publicado: (2023)

Differentiation of bacterial and non-bacterial community-acquired pneumonia by thin-section computed tomography
por: Ito, Isao, et al.
Publicado: (2009)

Fatal community-acquired Bacillus cereus pneumonia in an immunocompetent adult man: a case report
por: Ishida, Ryosuke, et al.
Publicado: (2019)

Development and validation of a prognostic scoring model for Mycobacterium avium complex lung disease: an observational cohort study
por: Kumagai, Shogo, et al.
Publicado: (2017)

517. Impact of Doxycycline in Place of Azithromycin for Community-Acquired Pneumonia on Clostridium difficile Infections
por: John, Jamie, et al.
Publicado: (2018)

Comparative Effectiveness of β-lactams Vs Azithromycin for Treatment of Outpatient Pediatric Community-acquired Pneumonia
por: Handy, Lori, et al.
Publicado: (2017)

66. Impact of a Pharmacist-Driven Azithromycin De-escalation Protocol for Community-Acquired Pneumonia
por: Shakeraneh, Pegah, et al.
Publicado: (2020)

Prognostic significance of malnutrition for long-term mortality in community-acquired pneumonia: a propensity score matched analysis
por: Yeo, Hye Ju, et al.
Publicado: (2019)

Addition of Baricitinib to COVID-19 Treatment Does Not Increase Bacterial Infection Compared to Standard Therapy: A Single-center Retrospective Study
por: Kobe, Hiroshi, et al.
Publicado: (2022)

Research on the economic loss of hospital-acquired pneumonia caused by Klebsiella pneumonia base on propensity score matching
por: Zhong, Xiao, et al.
Publicado: (2021)

Levofloxacin versus ceftriaxone and azithromycin for treating community-acquired pneumonia: a randomized clinical trial study
por: Yadegarynia, Davood, et al.
Publicado: (2022)

Real-world Biapenem vs. Meropenem in the treatment of severe community-acquired pneumonia in children: A propensity score matching analysis
por: Tao, Xuemei, et al.
Publicado: (2022)

Prognostic assessment in community-acquired pneumonia by pneumonia severity scores and biomarkers
por: Dusemund, F, et al.
Publicado: (2010)

Biomarkers and clinical scoring systems in community-acquired pneumonia
por: Karakioulaki, Meropi, et al.
Publicado: (2019)

A new severity score for community-acquired pneumonia: PARB score
por: Uchiyama, N, et al.
Publicado: (2010)

Community-acquired, hospital-acquired, and healthcare-associated pneumonia caused by Pseudomonas aeruginosa
por: Fujii, Ayumi, et al.
Publicado: (2014)

Comparative efficacy of azithromycin versus clarithromycin in combination with beta-lactams to treat community-acquired pneumonia in hospitalized patients: a systematic review
por: Al-Salloum, Jumana, et al.
Publicado: (2021)

2197. Ceftriaxone Monotherapy vs. Ceftriaxone Plus Azithromycin for the Treatment of Community-Acquired Pneumonia in Hospitalized, Non-ICU Patients
por: Murter, Forrest, et al.
Publicado: (2019)

2207. Impact of an Intervention Bundle on Azithromycin Use and 5-Day Durations of Therapy for Ambulatory Pediatric Community Acquired Pneumonia
por: Weber, Matthew J, et al.
Publicado: (2023)

Hospital-Acquired Pneumonia among Inpatients via the Emergency Department: A Propensity-Score Matched Analysis
por: Min, Jin-young, et al.
Publicado: (2018)

Severity of illness scoring systems in community-acquired Legionella pneumonia
por: Simonsen, Ø, et al.
Publicado: (2010)

Severe Legionella Pneumonia in Which Serial Testing by Ribotest(Ⓡ) Legionella was Useful for the Diagnosis
por: Motokura, Yumi, et al.
Publicado: (2023)

Impact of Administering Intravenous Azithromycin within 7 Days of Hospitalization for Influenza Virus Pneumonia: A Propensity Score Analysis Using a Nationwide Administrative Database
por: Tokito, Takatomo, et al.
Publicado: (2023)

Scored minor criteria for severe community-acquired pneumonia predicted better
por: Guo, Qi, et al.
Publicado: (2019)

AI-based disease risk score for community-acquired pneumonia hospitalization
por: Shakibfar, Saeed, et al.
Publicado: (2023)

Cost-Effectiveness Analysis of Xiyanping Injection (Andrographolide Sulfonate) for Treatment of Adult Community Acquired Pneumonia: A Retrospective, Propensity Score-Matched Cohort Study
por: Shi, Honghao, et al.
Publicado: (2019)

Pneumonia Due to Human Coronavirus OC43 in an Immunocompetent Adult Detected by Multiplex Polymerase Chain Reaction
por: Kawataki, Masanori, et al.
Publicado: (2021)

COMMUNITY-ACQUIRED PNEUMONIA
por: Haas, Andrew R., et al.
Publicado: (2009)

Community-acquired pneumonia
por: File, Thomas M
Publicado: (2003)

Community-Acquired Pneumonia
por: Sialer, Salvador, et al.
Publicado: (2014)

Community Acquired Pneumonia
por: Wunderink, Richard G., et al.
Publicado: (2016)

Community-Acquired Pneumonia
por: Boza Costagliola, María Lina
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t231glps53q6th48fspdp0edmk